Since its 2021 launch, Novo Nordisk’s Wegovy set the stage for the next generation of anti-obesity drugs that target the gut’s weight-regulating mechanisms. Now, a new drug on the scene promises to be more effective and safer than any other weight loss drug before.
Subscribe to:
Post Comments (Atom)
< + > GE Healthcare Uses DICOM Data and Image Clarity to Improve Radiology Workflows
Clarity matters in healthcare operations. When imaging teams understand how long exams actually take and radiologists see what they need to ...
No comments:
Post a Comment